These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7166179)

  • 21. Effects of the fenamates on the threshold of pain.
    Haward LR
    Ann Phys Med; 1966; Suppl():55-7. PubMed ID: 4895007
    [No Abstract]   [Full Text] [Related]  

  • 22. Biochemical properties of anti-inflammatory drugs. XI. Structure-action relationship for the uncoupling of oxidative phosphorylation and inhibition of chymotrypsin by N-substituted anthranilates and related compounds.
    Whitehouse MW
    Biochem Pharmacol; 1967 May; 16(5):753-60. PubMed ID: 6036726
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacokinetics of tolfenamic acid: disposition in bile, blood and urine after intravenous administration to man.
    Pentikäinen PJ; Tokola O; Alhava E; Penttilä A
    Eur J Clin Pharmacol; 1984; 27(3):349-54. PubMed ID: 6334608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structures of mefenamic acid metabolites from human urine.
    Sato J; Yamane Y; Ito K; Bando H
    Biol Pharm Bull; 1993 Aug; 16(8):811-2. PubMed ID: 8220331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infrared studies of the polymorphic states of the fenamates.
    Gilpin RK; Zhou W
    J Pharm Biomed Anal; 2005 Mar; 37(3):509-15. PubMed ID: 15740911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fate and disposition of bromocriptine in animals and man. I: structure elucidation of the metabolites.
    Maurer G; Schreier E; Delaborde S; Loosli HR; Nufer R; Shukla AP
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):281-92. PubMed ID: 7166180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7.
    Gaganis P; Miners JO; Knights KM
    Biochem Pharmacol; 2007 May; 73(10):1683-91. PubMed ID: 17343829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biotransformation of 12C- and 2-13C-labeled methyl tert-butyl ether, ethyl tert-butyl ether, and tert-butyl alcohol in rats: identification of metabolites in urine by 13C nuclear magnetic resonance and gas chromatography/mass spectrometry.
    Bernauer U; Amberg A; Scheutzow D; Dekant W
    Chem Res Toxicol; 1998 Jun; 11(6):651-8. PubMed ID: 9625733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural studies of analgesics and their interactions. XII. Structure and interactions of anti-inflammatory fenamates. A concerted crystallographic and theoretical conformational study.
    Dhanaraj V; Vijayan M
    Acta Crystallogr B; 1988 Aug; 44 ( Pt 4)():406-12. PubMed ID: 3271554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of tolfenamic acid and its detection time in urine after intravenous administration of the drug in camels (Camelus dromedarius).
    Wasfi IA; ElGhazali M; Hadi AA; Zorob O; Boni NS; Alkatheeri NA; Barezaiq IM
    Am J Vet Res; 1998 Nov; 59(11):1451-8. PubMed ID: 9829406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man.
    Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E
    Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism of isobutylnaphthyl acetic acid in rats: determination of the chemical structures of metabolites.
    Achtert G; Borchers F; Jacquot C; Christen MO
    Eur J Drug Metab Pharmacokinet; 1989; 14(1):29-34. PubMed ID: 2759131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow-injection spectrofluorimetric determination of flufenamic and mefenamic acid in pharmaceuticals.
    Albero MI; Sanchez-Pedreño C; Garcia MS
    J Pharm Biomed Anal; 1995 Aug; 13(9):1113-7. PubMed ID: 8573636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biotransformation of hexapropymate in man. Part 2: Isolation and identification of metabolites.
    Leyssens L; van Boven M; Daenens P
    Pharmazie; 1984 Feb; 39(2):114-7. PubMed ID: 6718477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of etofenamate. Particular determination in biological material (author's transl)].
    Dell HD; Fiedler J; Wäsche B
    Arzneimittelforschung; 1977; 27(6B):1312-6. PubMed ID: 579119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physicochemical properties and uncoupling activity of 3'-substituted analogues of N-phenylanthranilic acid.
    Terada H; Muraoka S
    Mol Pharmacol; 1972 Jan; 8(1):95-103. PubMed ID: 5061521
    [No Abstract]   [Full Text] [Related]  

  • 37. Thyroid hormone uptake by hepatocytes: structure-activity relationships of phenylanthranilic acids with inhibitory activity.
    Chalmers DK; Scholz GH; Topliss DJ; Kolliniatis E; Munro SL; Craik DJ; Iskander MN; Stockigt JR
    J Med Chem; 1993 Apr; 36(9):1272-7. PubMed ID: 8487264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary metabolites of clomethiazole. Detection and structural analysis by gas chromatography-mass spectrometry.
    Ende M; Spiteller G; Remberg G; Heipertz R
    Arzneimittelforschung; 1979; 29(11):1655-8. PubMed ID: 543872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fenamates as Potential Therapeutics for Neurodegenerative Disorders.
    Hill J; Zawia NH
    Cells; 2021 Mar; 10(3):. PubMed ID: 33809987
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.